The biology and management of systemic anaplastic large cell lymphoma
about
Enteropathy-Associated T-Cell Lymphoma.Diagnostic, prognostic and therapeutic role of CD30 in lymphoma.The heterogeneous landscape of ALK negative ALCL.Breast Implant-Associated Anaplastic Large Cell Lymphoma (ALCL): A Case ReportRedundant and nonredundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice.Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes.Partial deletion of the ALK gene in ALK-positive anaplastic large cell lymphoma.Use of brentuximab vedotin as salvage therapy pre-allogeneic stem cell transplantation in relapsed/refractory CD30 positive lympho-proliferative disorders: a single centre experience.Genetic Landscape and Classification of Peripheral T Cell Lymphomas.Primary Gastric ALK-negative EBV-negative Anaplastic Large Cell Lymphoma Presenting with Iron Deficiency Anemia.Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma.Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency.ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.Epigenetic supersimilarity of monozygotic twin pairs.ALK expression plays different roles in anaplastic large-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+ patients in a Chinese population.The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study.Brentuximab vedotin: clinical updates and practical guidance.Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding.Mut2Vec: distributed representation of cancerous mutations.
P2860
Q30239728-7332CF8B-F0ED-4E83-AB8E-853EA7493A62Q30240160-91806F34-9F4D-44A2-AD44-B406AB78F6F4Q33567012-696BC33A-5046-450E-B1A4-7637D2FF9103Q33769443-676C3066-BB33-47BC-8583-189F2452DA05Q36675069-B7789916-DF7F-467C-8E57-6775D8EB0242Q37708848-EABA320D-967A-4387-850F-763AD8307482Q38700613-8B0FAFB7-E84D-4DBC-9F6F-703165281933Q39155963-79D00AED-B7F1-4CFD-94B7-6929039B607AQ39183278-F9FCADC9-754E-40D9-B996-FD1A637038A0Q40144667-E80F3E41-33A3-4B22-B042-261BE792B584Q40519524-E9A22BC2-33D8-4B4C-8161-F4B5558E0FA1Q42199612-C9BEFACB-02D3-41C7-A668-231BB61FF12EQ46603813-2C780677-BB5D-4EB4-9237-3685580B95DEQ47196130-52292A85-6F6A-4F49-B290-D7F6DB444E2AQ47575958-AAA45078-0863-44E3-932F-7CE3C69B99D7Q48172795-B0A24F1E-555C-4EFF-8DA3-7A099124EBB8Q49282959-973075F8-AC05-4975-BC70-8D56CA7ED717Q51567596-BC2DA4DD-C1BD-4860-BF29-60CD0E74BB63Q52561814-845751D5-0563-4CB1-B105-7F6DA4B5B33E
P2860
The biology and management of systemic anaplastic large cell lymphoma
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The biology and management of systemic anaplastic large cell lymphoma
@ast
The biology and management of systemic anaplastic large cell lymphoma
@en
The biology and management of systemic anaplastic large cell lymphoma
@nl
type
label
The biology and management of systemic anaplastic large cell lymphoma
@ast
The biology and management of systemic anaplastic large cell lymphoma
@en
The biology and management of systemic anaplastic large cell lymphoma
@nl
prefLabel
The biology and management of systemic anaplastic large cell lymphoma
@ast
The biology and management of systemic anaplastic large cell lymphoma
@en
The biology and management of systemic anaplastic large cell lymphoma
@nl
P1433
P1476
The biology and management of systemic anaplastic large cell lymphoma
@en
P2093
G. Hapgood
K. J. Savage
P356
10.1182/BLOOD-2014-10-567461
P407
P577
2015-07-02T00:00:00Z